Molecular Therapeutics

Home
Research
Department of Molecular Therapeutics
>> Molecular Therapeutics - Chairman's Overview

Overview Faculty

Overview Cancer Biology Cell and Molecular Biology Chemical Physiology Chemistry C.N.A.D. Immunology and Microbial Science Infectious Diseases Integrative Structural and Computational Biology Metabolism & Aging Molecular and Cellular Neuroscience Molecular and Experimental Molecular Therapeutics Neuroscience

Overview Center for Integrative Molecular Biosciences Center for Metabolomics Dorris Neuroscience Center Molecular Screening Center IAVI's Neutralizing Antibody Center Pearson Center for Alcohol and Addiction Research Scripps-Vanderbilt Human Chemical Sciences Institute Scripps Translational Science Institute The Skaggs Institute for Chemical Biology Translational Research Institute Worm Institute

Consortia Research Areas Technology Cores & Shared Services Technology Development Affinity Groups Postdoctoral Resources

Molecular Therapeutics

Chairman's Overview

Patrick Griffin, Ph.D.

Patrick Griffin, Ph.D.

The Department of Molecular Therapeutics was established at Scripps Florida in 2007. The department focuses on chemical biology approaches to dissecting signaling pathways and transcriptional programs, using state-of-the-art, multi-disciplinary technology and methodology and a variety of model systems for target identification, validation and pre-clinical studies. Currently there are ten faculty members in the department. These investigators have created strong research programs in areas such as neurodegeneration, addiction, immune disorders, cancer, metabolic disease, and novel cell therapeutics.